Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
Claudio Laudani, Cardiovascular Disease Fellow UNICT, Post-Doc Research Scholar UFHealth JAX, shared on LinkedIn:
”Inflammation is a key driver of ischemic heart disease and myocardial infarction, having a central role in both the arterial wall and myocardial tissue.
Recently, novel approaches have reignited the interest in anti-inflammatory strategies after acute myocardial infarction.
However, key knowledge gaps remain regarding potential class effects, drug choice, patient selection, and the optimal administration timing.
In this state of the art review, we summarize current knowledge and future perspectives on the role of inflammation in patients with myocardial infarction, as well as potential targets and pharmacological treatments being currently under development.”
Read the full article in JACC.
Article: Targeting Inflammation After Acute Myocardial Infarction
Authors: Antonino Imbesi, Antonio Greco, Marco Spagnolo, Claudio Laudani, Carmelo Raffo, Simone Finocchiaro, Placido Maria Mazzone, Davide Landolina, Maria Sara Mauro, Luigi Cutore, Giacinto Di Leo, Denise Cristiana Faro, Nicola Ammirabile, Daniele Giacoppo, Davide Capodanno

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand
-
Aug 26, 2026, 13:54Giuseppe Biondi Zoccai: Congratulations to the Next Editor-in-Chief of the EHJ
-
Aug 26, 2026, 13:25Omar Adwan: Abnormal Nuclear Morphology of Neutrophil
-
Aug 26, 2026, 13:05Preventing Thrombosis with WTDay26
-
Aug 26, 2026, 10:09Gemma Figtree: How Well Do We Predict Heart Attack Risk in Women?
-
Aug 26, 2026, 10:06Understanding and Managing Fatigue in ITP – ITP Support Association
-
Aug 26, 2026, 10:04Abdul Muqtadir Abbasi: When a High INR Hides a Thrombotic Cancer
-
Aug 26, 2026, 09:42Mohammed Alo: What’s Wrong With the New Blood Pressure Guidelines?